Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders.
Established and novel disease-modifying treatments in multiple sclerosis.
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
Concurrent acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child.
Conversion of adult human peripheral blood mononuclear cells into induced neural stem cell by using episomal vectors.
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.
Estimating the marginal effect of socioeconomic factors on the demand of specialty drugs.
Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
Multiple sclerosis: Preventing progression and disability in MS-when to treat?
Emerging roles of microRNAs in chronic pain.
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
Extracellular Acidic pH Inhibits Oligodendrocyte Precursor Viability, Migration, and Differentiation.
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico: Results from a Large Patient Support Program in Mexico.
Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
A case of tumor-like inflammatory demyelinating disease with progressive brain and spinal cord involvement.
Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
The dual task-cost of standing balance affects quality of life in mildly disabled MS people.
Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
An unusually dry story.

Pages